$2.5 Billion is the total value of HealthCor Management, L.P.'s 40 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 80.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $177,822,000 | +651.1% | 1,306,170 | +558.5% | 7.12% | +617.4% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $159,430,000 | +135.4% | 511,370 | +122.7% | 6.38% | +124.8% |
| MDT | Buy | MEDTRONIC PLC | $145,712,000 | +73.6% | 1,402,160 | +53.2% | 5.83% | +65.8% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $139,071,000 | +523.9% | 1,790,310 | +346.4% | 5.57% | +495.9% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $134,159,000 | -1.1% | 1,129,948 | -5.7% | 5.37% | -5.5% |
| IQV | Buy | IQVIA HLDGS INC | $132,526,000 | +71.5% | 840,740 | +54.3% | 5.30% | +63.8% |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $130,713,000 | -15.3% | 8,873,953 | -6.6% | 5.23% | -19.1% |
| ABBV | Buy | ABBVIE INC | $115,522,000 | -10.7% | 1,318,900 | +0.1% | 4.62% | -14.7% |
| HCA | Buy | HCA HEALTHCARE INC | $115,492,000 | +48.5% | 926,310 | +15.6% | 4.62% | +41.9% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $106,532,000 | +202.1% | 190,310 | +236.5% | 4.26% | +188.5% |
| NVRO | Sell | NEVRO CORP | $101,825,000 | -19.1% | 730,977 | -30.7% | 4.08% | -22.8% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $98,614,000 | +1225.8% | 362,390 | +1314.5% | 3.95% | +1165.1% |
| HUM | Buy | HUMANA INC | $94,752,000 | +251.3% | 228,930 | +229.2% | 3.79% | +235.6% |
| GH | Buy | GUARDANT HEALTH INC | $89,170,000 | +52.9% | 797,730 | +11.0% | 3.57% | +46.1% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $89,147,000 | +105.4% | 927,070 | +160.6% | 3.57% | +96.3% |
| COO | New | COOPER COS INC | $81,428,000 | – | 241,540 | +100.0% | 3.26% | – |
| ARCT | Buy | ARCTURUS THERAPEUTICS HLDGS | $68,402,000 | +1453.5% | 1,594,452 | +1592.6% | 2.74% | +1388.0% |
| RPRX | Buy | ROYALTY PHARMA PLC | $62,954,000 | +41.5% | 1,496,410 | +63.3% | 2.52% | +35.2% |
| AMGN | Sell | AMGEN INC | $59,407,000 | -2.8% | 233,740 | -9.8% | 2.38% | -7.1% |
| TFX | New | TELEFLEX INCORPORATED | $56,224,000 | – | 165,160 | +100.0% | 2.25% | – |
| CRL | Buy | CHARLES RIV LABS INTL INC | $54,853,000 | +212.3% | 242,230 | +140.5% | 2.20% | +198.2% |
| MD | Sell | MEDNAX INC | $52,654,000 | -9.1% | 3,234,280 | -4.5% | 2.11% | -13.2% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $43,231,000 | +42.9% | 578,030 | +20.3% | 1.73% | +36.5% |
| DHR | Sell | DANAHER CORPORATION | $31,137,000 | -53.3% | 144,600 | -61.6% | 1.25% | -55.3% |
| THC | Buy | TENET HEALTHCARE CORP | $27,328,000 | +1076.9% | 1,114,980 | +769.5% | 1.09% | +1027.8% |
| SYK | New | STRYKER CORPORATION | $24,702,000 | – | 118,550 | +100.0% | 0.99% | – |
| ARNA | New | ARENA PHARMACEUTICALS INCcall | $23,185,000 | – | 310,000 | +100.0% | 0.93% | – |
| EW | New | EDWARDS LIFESCIENCES CORP | $17,869,000 | – | 223,860 | +100.0% | 0.72% | – |
| ZYME | New | ZYMEWORKS INC | $16,096,000 | – | 345,550 | +100.0% | 0.64% | – |
| ARCT | New | ARCTURUS THERAPEUTICS HLDGScall | $8,580,000 | – | 200,000 | +100.0% | 0.34% | – |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $8,540,000 | – | 519,490 | +100.0% | 0.34% | – |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $7,566,000 | -87.9% | 125,500 | -88.2% | 0.30% | -88.4% |
| AMWL | New | AMERICAN WELL CORPcl a | $7,410,000 | – | 250,000 | +100.0% | 0.30% | – |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $4,806,000 | -64.5% | 14,680 | -70.2% | 0.19% | -66.1% |
| ATHA | New | ATHIRA PHARMA INC | $4,015,000 | – | 217,500 | +100.0% | 0.16% | – |
| DYN | New | DYNE THERAPEUTICS INC | $2,423,000 | – | 120,000 | +100.0% | 0.10% | – |
| INCY | New | INCYTE CORP | $2,026,000 | – | 22,580 | +100.0% | 0.08% | – |
| OM | New | OUTSET MED INC | $1,750,000 | – | 35,000 | +100.0% | 0.07% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $1,111,000 | – | 14,600 | +100.0% | 0.04% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $475,000 | – | 32,200 | +100.0% | 0.02% | – |
| RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -50,000 | -100.0% | -0.06% | – |
| GBIO | Exit | GENERATION BIO CO | $0 | – | -100,000 | -100.0% | -0.09% | – |
| AKUS | Exit | AKOUOS INC | $0 | – | -100,000 | -100.0% | -0.09% | – |
| FUSN | Exit | FUSION PHARMACEUTICALS INC | $0 | – | -150,000 | -100.0% | -0.11% | – |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -75,000 | -100.0% | -0.13% | – |
| BMYRT | Exit | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $0 | – | -1,115,000 | -100.0% | -0.17% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -1,200,000 | -100.0% | -0.23% | – |
| SDC | Exit | SMILEDIRECTCLUB INC | $0 | – | -700,000 | -100.0% | -0.23% | – |
| RTIX | Exit | RTI SURGICAL HOLDINGS INC | $0 | – | -2,158,644 | -100.0% | -0.29% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -172,310 | -100.0% | -0.56% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -260,700 | -100.0% | -0.67% | – |
| ADPT | Exit | ADAPTIVE BIOTECHNOLOGIES COR | $0 | – | -345,370 | -100.0% | -0.70% | – |
| PCRX | Exit | PACIRA BIOSCIENCES | $0 | – | -405,040 | -100.0% | -0.89% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -503,920 | -100.0% | -1.41% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -1,025,000 | -100.0% | -2.08% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -969,580 | -100.0% | -2.26% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -152,180 | -100.0% | -2.31% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -743,018 | -100.0% | -2.43% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -638,180 | -100.0% | -2.44% | – |
| LIVN | Exit | LIVANOVA PLC | $0 | – | -1,445,500 | -100.0% | -2.92% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -666,510 | -100.0% | -3.13% | – |
| EHC | Exit | ENCOMPASS HEALTH CORP | $0 | – | -1,246,419 | -100.0% | -3.23% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -472,360 | -100.0% | -3.71% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -554,010 | -100.0% | -3.86% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -606,470 | -100.0% | -6.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.